Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research

Clinical trial NCT06716164 · RECRUITING

Trial details

NCT number: NCT06716164
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma,B Cell

Start date: 2024-12-01
Primary completion: 2026-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.